Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2

Table 1 Baseline characteristics, n (%)

Characteristics		ICU admission, n = 21	Non-ICU admission, n = 75	P value
Age at transplant (years)		54.7 ± 13.9	50.4 ± 15.2	0.68
Age at COVID-19 diagnosis (years)		59.5 ± 14.1	57.1 ± 14.4	0.97
Male		16 (76)	40 (53)	0.06
Nonwhite		4 (19)	20 (27)	0.50
Cause of ESKD	Diabetes mellitus	6 (28)	21 (28)	0.56
	Hypertension	4 (19)	9 (12)
	Glomerular disease	8 (38)	23 (31)
	Polycystic kidney disease	0	6 (8)
	Other	3 (14)	16 (21)
Living donor		3 (14)	28 (37)	0.04
Previous transplant		3 (14)	23 (31)	0.14
Maintenance immunosuppressive	Tacrolimus + Mycophenolic acid + prednisone	18 (86)	53 (71)	0.17
	Prednisone based immunosuppression	19 (91)	69 (91)	0.98
Vaccinated		11 (52)	44 (59)	0.61
Rejection within six months before COVID-19		0	2 (3)	0.45
Baseline serum creatinine before COVID-19 (mg/dL)		1.57 ± 0.73	1.89 ± 1.57	< 0.001
Baseline eGFR before COVID-19 (mL/m2)		53.7 ± 21.1	42.3 ± 19.5	0.61
The interval from transplant to the first COVID-19 (month)		58.5 ± 54.7	81.8 ± 68.4	0.26

COVID-19: Coronavirus disease 2019; eGFR: Estimated glomerular filtration rate; ICU: Intensive care unit; ESKD: End-stage kidney disease.